We've responded to the joint Intellectual Property Office (IPO), Department for Science, Innovation and Technology (DSIT) and Department for Culture, Media, and Sport (DCMS) consultation on Copyright and Artificial Intelligence (AI).
In our submission, we reiterate the economic growth potential of UK life sciences, and welcome its recognition within the Industrial Strategy as a priority sector. We call for government to turn its attention to the six key areas outlined within the Industrial Strategy, and list a number of priority investments within them.
The BIA has responded to the DBT consultation on Invest 2035: The UK's modern industrial strategy. The BIA welcomes this open consultation, as well as the government's designation of the life sciences as one of the key growth-driving sectors that the strategy will focus on.
NHS England has published a consultation document which sets out proposals for updating the NHS Commercial Framework for New Medicines. The BIA has responded to the consultation on updating the NHS commercial framework for new medicines.
The BIA has responded to the consultation on the Budget Impact Test (BIT) threshold. We welcome the proposal to increase the BIT threshold as this will help to ensure timely patient access to innovative medicines.
The BIA has responded to the HM Treasury, Department for Work and Pensions, and Ministry of Housing, Communities and Local Government's consultation on the Pension Investment Review.
Our submission urges caution and careful consideration of the impacts on life sciences as the government determines how to move forward with the taxation of capital gains.
We call for stability and the retention of already established commitments and programmes including R&D tax relief, pensions reform, and various other funding mechanisms such as the UKRI and Innovate UK budgets.
